Search the Newsreel

Earnings Flash (LOMA) Loma Negra Reports Q2 Revenue Ps.238.05B

Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has reported its Q2 revenue as Ps.238.05 billion. The company operates in the construction materials sector, producing and distributing cement, masonry cement, aggregates, and concrete in Argentina and Paraguay. This financial update follows previous earnings calls …

Emergent BioSolutions Announces Restructuring Amid Turnaround Efforts

Cogent targets 6%-8% multiyear revenue growth while continuing Sprint data center monetization and 2027 notes refinancing

Earnings Call Insights: Cogent Communications (CCOI) Q2 2026 MANAGEMENT VIEW * “We have made significant progress in several areas: our data center monetization, our net leverage reduction, our cost reduction, and completion of various integration projects,” said Founder, Chairman, CEO & President David Schaeffer. …

Loma Negra Reports 2Q26 results

BUENOS AIRES, Argentina, Aug. 6, 2026 /PRNewswire/ -- Loma Negra, (NYSE: LOMA; BYMA: LOMA), ("Loma Negra" or the "Company"), the leading cement producer in Argentina, today announced results for the three-month period ended June 30, 2026 (our "2Q26 Results"). 2Q26 Key Highlights Net sales …

Emergent BioSolutions laying off dozens, shedding real estate as Narcan competition strains profits

Emergent BioSolutions is undergoing significant restructuring, including layoffs and real estate divestment, to cut costs. These measures are a response to increased competition for its key product, Narcan, an over-the-counter opioid overdose reversal spray. The company has been implementing these changes since Joe Papa …

Cogent Communications (NASDAQ:CCOI) Trading Down 11.6% - Should You Sell?

Cogent Communications (NASDAQ:CCOI) shares dropped 11.6% after reporting mixed Q2 results. While GAAP EPS beat expectations due to a data-center sale, core service revenue declined, and adjusted EPS showed a loss. The company faces ongoing legal pressure from a securities class action and has …

CCOI Deadline Alert: SueWallSt Reminds COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI) Investors of Securities Class Action Deadline on September 21, 2026

SueWallSt is reminding investors of Cogent Communications Holdings, Inc. (CCOI) about a securities class action lawsuit with a lead plaintiff deadline of September 21, 2026. The lawsuit alleges that Cogent made misleading statements regarding its wavelength-driven growth, dividend strength, and the success of its …

Emergent BioSolutions | 10-Q: Q2 2026 Earnings Report

This article provides the Q2 2026 earnings report for Emergent BioSolutions. It is a quarterly filing (10-Q) that details the company's financial performance during the second quarter of 2026.

Lithium Argentina AG (LAR.US) will release its earnings report before market open on August 11.

Lithium Argentina AG (LAR.US) is scheduled to release its earnings report before the market opens on August 11. Investors and analysts will be watching closely for the company's financial performance.

Gentex Corporation (GNTX) Stock Price, News, Quote & History

This page provides comprehensive financial information for Gentex Corporation (GNTX), an auto parts company specializing in digital vision, connected car, and dimmable glass technologies. It includes real-time stock price, historical data, key financial metrics, analyst ratings, and a company overview. The article highlights Gentex's …

Cogent Communications Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CCOI) 2026-08-06

Cogent Communications Holdings, Inc. published its Q2 2026 earnings call presentation. The company reported an EPS of -$0.45, beating estimates by $0.50, and revenue of $235.56M, missing estimates by $4.23M with a 4.34% year-over-year decrease. The presentation was released in conjunction with their earnings …

Lithium Argentina Secures $220 Million Debt to Fund Cauchari-Olaroz Expansion

Lithium Argentina (TSE:LAR) has secured $220 million in new unsecured debt facilities to expand its Cauchari-Olaroz lithium brine operation in Argentina. This financing, backed by Ganfeng Lithium, will support a planned Stage 2 expansion to increase production by an additional 45,000 tonnes per year …

Cogent (CCOI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Cogent Communications (CCOI) reported revenue of $235.56 million, down 4.3% over the same period last year. EPS came in at -$0.80, compared to -$1.21 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

Forgent Power Solutions (FPS) is Positioning for Long-Term Success through Innovation and Growth

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

Is Cogent Communications (CCOI) a Value Play After Q2 Earnings M

CCC Intelligent Solutions Holdings (CCC) Performance Solid, But Prospective Returns Dwindle

Conestoga Capital Advisors, an asset management company, reported a positive shift towards Small Caps in its Q2 2026 investor letter. Despite a strong market for the Russell 2000 Growth Index, Conestoga's quality-focused strategies were impacted by uneven leadership, mirroring the Tech Bubble. The firm …

Cogent (NASDAQ:CCOI) Misses Q2 CY2026 Sales Expectations

Cogent (NASDAQ:CCOI) Misses Q2 CY2026 Sales Expectations Internet service provider Cogent Communications (NASDAQ:CCOI) fell short of the market's revenue expectations in Q2 CY2026, with sales falling 4.3% year on year to $235.6 million. Its GAAP profit of $1.38 per share was significantly above analysts' …

Cogent Communications (CCOI) Reports Q2 Loss, Misses Revenue Estimates

Cogent Communications (CCOI) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $1.12. This compares to a loss of $1.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

Bank of America Corp DE Boosts Stake in Banco Bilbao Viscaya Argentaria S.A. $BBVA

Cogent Communications Q2 Adjusted Gross Profi

The article "Cogent Communications Q2 Adjusted Gross Profi" appears to be incomplete. It is likely a placeholder or an error in content retrieval, as only the title and the word "Document" are present.

Cogent Communications Reports Second Quarter 2026 Results

Cogent Communications Holdings, Inc. announced its Q2 2026 results, highlighting service revenue of $235.6 million. Key financial achievements include the sale of ten data centers for $224.2 million, resulting in a $130.7 million gain, and an EBITDA, as adjusted, of $71.1 million. The company …

Emergent BioSolutions Inc. 2026: Revenue $234.3M, EPS ($3.49) — 10-Q Summary

Emergent BioSolutions Inc. reported its second-quarter 2026 results, with revenue increasing to $234.3M from $140.9M year-over-year. Despite this growth, the company recorded a net loss of ($180.2M) and diluted EPS of ($3.49), primarily due to a $191M non-cash impairment on NARCAN® intangible assets. The …

Morgan Stanley Maintains VERSIGENT PLC(VGNT.US) With Buy Rating, Raises Target Price to $58

Morgan Stanley has reiterated its "Buy" rating on VERSIGENT PLC (VGNT.US) and increased its target price for the company's shares to $58. This indicates a continued positive outlook from the investment bank regarding VERSIGENT's future performance.

Versigent PLC Stock 12‑Month Price Target Raised to $55.9, Implies 22% Upside

Versigent PLC (VGNT) has seen its average 12-month price target increase to $55.9 from $55.2, with individual forecasts ranging from $52 to $60. This new target suggests a 22% potential upside based on the Aug. 4 closing price. The stock maintains a "Buy" consensus …

Argent BioPharma (ASX:RGT): Why Does Cannepil Development Pathway Matter?

Versigent Ord Shs When Issued (VGNT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Cogent Communications (CCOI) Earnings Date and Reports 2026

Loma Negra Compania Industrial Argentina (LOMA) Earnings Date and Reports 2026

Emergent BioSolutions (NYSE: EBS) posts Q2 loss, plans cost-cutting

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) is September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented the strength and growth of …

Argent BioPharma Advances CannEpil into U.S. Veterinary Market with New Development Program

Is Emergent BioSolutions Inc (EBS) Overvalued After Q2 Earnings

Emergent BioSolutions Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EBS) 2026-08-05

Key Points Interested in Emergent Biosolutions Inc.? Here are five stocks we like better. Q2 performance exceeded expectations: Revenue reached $234 million and adjusted EBITDA rose to $97 million, driven by accelerated medical countermeasure deliveries and strong U.S. government contract activity. NARCAN competition is …

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Emergent BioSolutions announced its second-quarter 2026 financial results, reporting total revenues of $234.3 million, a 66% increase year-over-year, and an adjusted net income of $30.9 million, up 134%. Despite a significant net loss due to a non-cash impairment charge, the company is implementing a …

COGENT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cogent Communications Holdings, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cogent (CCOI) To Contact Him Directly To Discuss Their Options If you purchased or acquired Cogent common stock between February 29, 2024 and May 1, 2026 and would like …

Emergent records $191.3M non-cash charge related to NARCAN asset group

Emergent BioSolutions reported Q2 2026 total revenues of $234.3 million, a 66% increase year-over-year, driven primarily by higher U.S. government sales of smallpox and other medical countermeasure products. Despite this revenue growth and improved adjusted net income and EBITDA, the company posted a GAAP …